{"title":"图书角","authors":"","doi":"10.1080/15321810600735007","DOIUrl":null,"url":null,"abstract":"In the first chapter of the book, the author, Dr. Lundbad introduces and defines proteome and proteomics. For the benefit of the reader, we quote here the first part of the introduction with which we agree. “Proteomics is an increasingly complex area of study that is expected to yield results important for the development of therapeutics, diagnostics and for the emerging discipline of theranostics, which emphasizes patient-specific therapeutics. What, however, exactly is proteomics? The term proteome dates back to 1995 when Humphrey-Smith and colleagues defined the proteome as “the total protein content of a genome.” Genome is defined as “a complete single set of the genetic material of a cell or of an organism; the complete set of genes in a gamete.” It would follow that proteomics is the study of the proteome. A variety of other definitions have been proposed for proteomics. Morrison and coworkers define the proteome as “the entire complement of proteins expressed by a cell at a point in time.” In such cases, proteomics would be the study of the proteome; however, this definition would exclude extracellular collections of proteins such as those found in blood plasma, urine, and lymphatic fluid. These latter studies use some of the tools of proteomics, such as twodimensional electrophoresis and mass spectrometry, but are clearly different from studies where isotope-coded affinity tag (ICAT) technology is used to study differential protein expression and are used to identify biomarkers for diagnostics and therapeutics. Whatever the precise definition, proteomics involves the study of complex mixtures of proteins and their interactions. This somewhat broader definition might be useful in that it extends the application of proteomics to diagnostics. The technologies that underlie proteomics quite likely will improve sufficiently in analytical capability to be valuable in personalized medicine.” According to the author, “The overall intent of the current book is to address issues that are not discussed in detail by others and to avoid, where Journal of Immunoassay & Immunochemistry, 27: 289–290, 2006 Copyright # Taylor & Francis Group, LLC ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810600735007","PeriodicalId":15987,"journal":{"name":"Journal of Immunoassay and Immunochemistry","volume":"32 1","pages":"289 - 290"},"PeriodicalIF":0.0000,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Book Corner\",\"authors\":\"\",\"doi\":\"10.1080/15321810600735007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the first chapter of the book, the author, Dr. Lundbad introduces and defines proteome and proteomics. For the benefit of the reader, we quote here the first part of the introduction with which we agree. “Proteomics is an increasingly complex area of study that is expected to yield results important for the development of therapeutics, diagnostics and for the emerging discipline of theranostics, which emphasizes patient-specific therapeutics. What, however, exactly is proteomics? The term proteome dates back to 1995 when Humphrey-Smith and colleagues defined the proteome as “the total protein content of a genome.” Genome is defined as “a complete single set of the genetic material of a cell or of an organism; the complete set of genes in a gamete.” It would follow that proteomics is the study of the proteome. A variety of other definitions have been proposed for proteomics. Morrison and coworkers define the proteome as “the entire complement of proteins expressed by a cell at a point in time.” In such cases, proteomics would be the study of the proteome; however, this definition would exclude extracellular collections of proteins such as those found in blood plasma, urine, and lymphatic fluid. These latter studies use some of the tools of proteomics, such as twodimensional electrophoresis and mass spectrometry, but are clearly different from studies where isotope-coded affinity tag (ICAT) technology is used to study differential protein expression and are used to identify biomarkers for diagnostics and therapeutics. Whatever the precise definition, proteomics involves the study of complex mixtures of proteins and their interactions. This somewhat broader definition might be useful in that it extends the application of proteomics to diagnostics. The technologies that underlie proteomics quite likely will improve sufficiently in analytical capability to be valuable in personalized medicine.” According to the author, “The overall intent of the current book is to address issues that are not discussed in detail by others and to avoid, where Journal of Immunoassay & Immunochemistry, 27: 289–290, 2006 Copyright # Taylor & Francis Group, LLC ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810600735007\",\"PeriodicalId\":15987,\"journal\":{\"name\":\"Journal of Immunoassay and Immunochemistry\",\"volume\":\"32 1\",\"pages\":\"289 - 290\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Immunoassay and Immunochemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/15321810600735007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Immunoassay and Immunochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15321810600735007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在书的第一章中,作者伦巴德博士介绍了蛋白质组学和蛋白质组学。为了读者的利益,我们在这里引用我们同意的引言的第一部分。“蛋白质组学是一个日益复杂的研究领域,有望对治疗学、诊断学和新兴的治疗学学科(强调患者特异性治疗)的发展产生重要的结果。然而,蛋白质组学究竟是什么?蛋白质组这个术语可以追溯到1995年,当时汉弗莱-史密斯和他的同事将蛋白质组定义为“基因组的总蛋白质含量”。基因组被定义为“细胞或生物体的完整的单一遗传物质;配子中的全套基因。”因此,蛋白质组学就是对蛋白质组的研究。对于蛋白质组学,人们提出了许多其他的定义。莫里森和同事将蛋白质组定义为“细胞在某一时间点表达的全部蛋白质”。在这种情况下,蛋白质组学就是研究蛋白质组;然而,这一定义将排除细胞外的蛋白质集合,如在血浆、尿液和淋巴液中发现的蛋白质。后者的研究使用了蛋白质组学的一些工具,如二维电泳和质谱,但与使用同位素编码亲和标签(ICAT)技术研究差异蛋白表达并用于识别诊断和治疗的生物标志物的研究明显不同。无论精确的定义是什么,蛋白质组学涉及研究蛋白质的复杂混合物及其相互作用。这个更广泛的定义可能是有用的,因为它将蛋白质组学的应用扩展到诊断领域。蛋白质组学的基础技术很可能会充分提高分析能力,从而在个性化医疗中发挥重要作用。”根据作者的观点,“目前这本书的总体意图是解决其他人没有详细讨论和避免的问题,《免疫分析与免疫化学杂志》,27:289-290,2006版权# Taylor & Francis Group, LLC ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810600735007
In the first chapter of the book, the author, Dr. Lundbad introduces and defines proteome and proteomics. For the benefit of the reader, we quote here the first part of the introduction with which we agree. “Proteomics is an increasingly complex area of study that is expected to yield results important for the development of therapeutics, diagnostics and for the emerging discipline of theranostics, which emphasizes patient-specific therapeutics. What, however, exactly is proteomics? The term proteome dates back to 1995 when Humphrey-Smith and colleagues defined the proteome as “the total protein content of a genome.” Genome is defined as “a complete single set of the genetic material of a cell or of an organism; the complete set of genes in a gamete.” It would follow that proteomics is the study of the proteome. A variety of other definitions have been proposed for proteomics. Morrison and coworkers define the proteome as “the entire complement of proteins expressed by a cell at a point in time.” In such cases, proteomics would be the study of the proteome; however, this definition would exclude extracellular collections of proteins such as those found in blood plasma, urine, and lymphatic fluid. These latter studies use some of the tools of proteomics, such as twodimensional electrophoresis and mass spectrometry, but are clearly different from studies where isotope-coded affinity tag (ICAT) technology is used to study differential protein expression and are used to identify biomarkers for diagnostics and therapeutics. Whatever the precise definition, proteomics involves the study of complex mixtures of proteins and their interactions. This somewhat broader definition might be useful in that it extends the application of proteomics to diagnostics. The technologies that underlie proteomics quite likely will improve sufficiently in analytical capability to be valuable in personalized medicine.” According to the author, “The overall intent of the current book is to address issues that are not discussed in detail by others and to avoid, where Journal of Immunoassay & Immunochemistry, 27: 289–290, 2006 Copyright # Taylor & Francis Group, LLC ISSN 1532-1819 print/1532-4230 online DOI: 10.1080/15321810600735007